These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors? Oprisiu-Fournier R; Faure S; Mazouz H; Boutitie F; Serot JM; Achard JM; Godefroy O; Hanon O; Temmar M; Albu A; Strandgaard S; Wang J; Black SE; Fournier A Expert Rev Neurother; 2009 Sep; 9(9):1289-305. PubMed ID: 19769445 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type 1 receptors in cerebral ischaemia-reperfusion: initiation of inflammation. Schulz R; Heusch G J Hypertens Suppl; 2006 Mar; 24(1):S123-9. PubMed ID: 16601565 [TBL] [Abstract][Full Text] [Related]
5. Blood pressure lowering in acute ischaemic stroke: an update on the role of angiotensin receptor blockers. Sigurdsson ST; Strandgaard S J Hypertens; 2007 Apr; 25(4):743-5. PubMed ID: 17351363 [No Abstract] [Full Text] [Related]
6. The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage. Iwai M; Chen R; Ide A; Iwanami J; Tomochika H; Tomono Y; Mogi M; Horiuchi M J Hypertens; 2006 Oct; 24(10):2023-31. PubMed ID: 16957563 [TBL] [Abstract][Full Text] [Related]
7. [Effect of angiotensin II and antagonists of the renin-angiotensin system on the cerebral circulation]. Adzhienko LM Eksp Klin Farmakol; 2000; 63(4):74-9. PubMed ID: 11022315 [No Abstract] [Full Text] [Related]
8. Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases. Mogi M; Horiuchi M Geriatr Gerontol Int; 2013 Jan; 13(1):13-8. PubMed ID: 22726823 [TBL] [Abstract][Full Text] [Related]
9. Vascular protection in brain ischemia. Rodríguez-Yáñez M; Castellanos M; Blanco M; Mosquera E; Castillo J Cerebrovasc Dis; 2006; 21 Suppl 2():21-9. PubMed ID: 16651811 [TBL] [Abstract][Full Text] [Related]
10. A sartan derivative with a very low angiotensin II receptor affinity ameliorates ischemic cerebral damage. Takizawa S; Dan T; Uesugi T; Nagata E; Takagi S; van Ypersele de Strihou C; Miyata T J Cereb Blood Flow Metab; 2009 Oct; 29(10):1665-72. PubMed ID: 19536069 [TBL] [Abstract][Full Text] [Related]
12. Role of angiotensin II in the response to endothelin-1 of goat cerebral arteries after ischemia-reperfusion. Salcedo A; Fernández N; García Villalón AL; Monge L; Narváez Sánchez R; Diéguez G Vascul Pharmacol; 2009; 50(5-6):160-5. PubMed ID: 19135174 [TBL] [Abstract][Full Text] [Related]
13. Importance of NOX1 for angiotensin II-induced cerebrovascular superoxide production and cortical infarct volume following ischemic stroke. Jackman KA; Miller AA; Drummond GR; Sobey CG Brain Res; 2009 Aug; 1286():215-20. PubMed ID: 19559686 [TBL] [Abstract][Full Text] [Related]
14. [Antihypertensive drugs and their effects on cerebral circulation]. Nagao T; Fujishima M Nihon Rinsho; 2000 Feb; 58 Suppl 2():237-40. PubMed ID: 11028331 [No Abstract] [Full Text] [Related]
15. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998 [TBL] [Abstract][Full Text] [Related]
16. Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system. Hamaguchi R; Takemori K; Inoue T; Masuno K; Ito H Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1151-5. PubMed ID: 18518883 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of the Anti-Ischemic Effect of Angiotensin II AT( 1 ) Receptor Antagonists in the Brain. Saavedra JM; Benicky J; Zhou J Cell Mol Neurobiol; 2006; 26(7-8):1099-111. PubMed ID: 16636899 [TBL] [Abstract][Full Text] [Related]
18. [Angiotensin II-receptor antagonists compared to other antihypertensives: still insufficient evidence for reducing the risk of cerebrovascular incidents]. Meerum Terwogt JM; Koopmans RP; Roos YB; van Montfrans GA Ned Tijdschr Geneeskd; 2008 Jan; 152(2):71-5. PubMed ID: 18265794 [TBL] [Abstract][Full Text] [Related]
19. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors. Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454 [TBL] [Abstract][Full Text] [Related]
20. The effect of enalapril on skin flap viability is independent of angiotensin II AT1 receptors. Pazoki-Toroudi H; Ajami M; Habibey R; Hajiaboli E; Firooz A Ann Plast Surg; 2009 Jun; 62(6):699-702. PubMed ID: 19461289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]